Cooper Companies, Inc. (The) (NYSE:COO)‘s stock had its “buy” rating restated by equities research analysts at Robert W. Baird in a note issued to investors on Thursday. They presently have a $251.00 price objective on the medical device company’s stock. Robert W. Baird’s target price suggests a potential upside of 1.90% from the stock’s previous close.

COO has been the topic of a number of other research reports. Piper Jaffray Companies upped their price target on Cooper Companies, Inc. (The) to $265.00 and gave the company an “overweight” rating in a research report on Wednesday, July 19th. BidaskClub cut Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Zacks Investment Research cut Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research report on Thursday, June 22nd. Guggenheim began coverage on Cooper Companies, Inc. (The) in a research report on Thursday, June 29th. They set a “neutral” rating on the stock. Finally, BMO Capital Markets reaffirmed an “outperform” rating and set a $255.00 price target (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $242.33.

Shares of Cooper Companies, Inc. (NYSE COO) opened at 246.33 on Thursday. The firm has a market capitalization of $12.03 billion, a PE ratio of 36.93 and a beta of 0.61. The stock has a 50 day moving average of $246.40 and a 200-day moving average of $219.29. Cooper Companies, Inc. has a 52 week low of $158.73 and a 52 week high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its quarterly earnings results on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.25 by $0.25. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The firm had revenue of $522.40 million for the quarter, compared to analysts’ expectations of $520.71 million. During the same quarter in the prior year, the firm earned $2.05 EPS. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. Equities analysts anticipate that Cooper Companies, Inc. will post $9.63 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Cooper Companies, Inc. (The) (COO) Rating Reiterated by Robert W. Baird” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/26/cooper-companies-inc-the-coo-rating-reiterated-by-robert-w-baird.html.

In related news, CEO Paul L. Remmell sold 9,294 shares of the stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the sale, the chief executive officer now owns 6,186 shares of the company’s stock, valued at approximately $1,536,973.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stanley Md Zinberg sold 816 shares of the firm’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $243.14, for a total value of $198,402.24. The disclosure for this sale can be found here. Insiders have sold a total of 67,331 shares of company stock worth $16,400,454 in the last three months. 1.60% of the stock is currently owned by insiders.

Hedge funds have recently added to or reduced their stakes in the stock. Lord Abbett & CO. LLC boosted its stake in Cooper Companies, Inc. (The) by 2.1% in the second quarter. Lord Abbett & CO. LLC now owns 405,831 shares of the medical device company’s stock valued at $97,164,000 after buying an additional 8,316 shares during the last quarter. Sentry Investment Management LLC boosted its stake in Cooper Companies, Inc. (The) by 0.7% in the second quarter. Sentry Investment Management LLC now owns 2,801 shares of the medical device company’s stock valued at $671,000 after buying an additional 19 shares during the last quarter. Toronto Dominion Bank boosted its stake in Cooper Companies, Inc. (The) by 25.3% in the second quarter. Toronto Dominion Bank now owns 16,552 shares of the medical device company’s stock valued at $3,963,000 after buying an additional 3,344 shares during the last quarter. Advisory Services Network LLC boosted its stake in Cooper Companies, Inc. (The) by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after buying an additional 107 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in Cooper Companies, Inc. (The) during the second quarter valued at $423,000. 98.06% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Analyst Recommendations for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.